Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
protocols.io is an open access platform dedicated to creating, sharing, and discovering scientific methods and protocols. Founded by scientists for scientists, it aims to address the challenge of reproducibility in research by providing a collaborative environment where detailed experimental procedures can be easily documented, versioned, peer-reviewed, and disseminated. The platform supports both public and private protocol development, catering to individual researchers, labs, and large organizations. In early 2023, protocols.io was acquired by Springer Nature, further integrating its capabilities into the broader scientific publishing and research ecosystem.
Serves as the main operational and development center for the protocols.io platform, including software engineering, product management, user support, and community engagement.
Located within the vibrant tech and biotech ecosystem of Berkeley, facilitating access to talent and proximity to leading research institutions like UC Berkeley.
As a company founded by scientists, the culture likely emphasizes collaboration, open communication, innovation, and a strong commitment to improving scientific practice. Post-acquisition by Springer Nature, it would integrate with a larger corporate culture while likely retaining its agile and mission-driven startup spirit.
The Berkeley location places protocols.io at the heart of a scientifically advanced community, allowing for direct engagement with users and thought leaders in various research fields.
protocols.io serves a global community of scientists and researchers across academic institutions, pharmaceutical companies, and biotech organizations. The platform is accessible worldwide, with users from virtually every country. While its core team was initially centered in Berkeley, it has embraced remote work and, post-acquisition by Springer Nature, leverages a global infrastructure to support its international user base with development, customer service, and community outreach.
1010 Grayson St, Ste C
Berkeley
CA
USA
Address: N/A (Remote Workforce)
Supports global user base, software development, and community engagement through a distributed team model, enhancing talent acquisition and operational flexibility.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, protocols.io' leadership includes:
protocols.io has been backed by several prominent investors over the years, including:
The most significant change in the last 12-18 months was the acquisition of protocols.io by Springer Nature in February 2023. The founding executive team, including CEO Lenny Teytelman, CTO Alexei Stoliartchouk, and COO Irina Makkaveeva, has largely remained with the company to ensure continuity and lead its integration and growth within Springer Nature. No other major public announcements of executive hires or exits have been noted for the core protocols.io leadership since the acquisition.
Discover the tools protocols.io uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
protocols.io likely follows common email format patterns for tech companies. Based on publicly available information and common structures, primary formats could include [first].[last]@protocols.io or [first_initial][last]@protocols.io.
[first].[last]@protocols.io or [first]@protocols.io
Format
lenny.teytelman@protocols.io or lenny@protocols.io
Example
80%
Success rate
Springer Nature • February 1, 2023
Springer Nature announced the acquisition of protocols.io, a secure platform for developing and sharing reproducible scientific methods. This move aims to enhance Springer Nature's portfolio of solutions supporting open research practices and improve research reproducibility....more
protocols.io Blog • October 25, 2022
protocols.io received a significant grant from the Chan Zuckerberg Initiative (CZI) to further develop its platform, focusing on improving the discoverability and usability of scientific protocols, particularly in biomedical research....more
protocols.io Blog • July 12, 2021
protocols.io announced a partnership with Gates Open Research to integrate protocol sharing into their publishing platform, aiming to enhance transparency and reproducibility of research funded by the Bill & Melinda Gates Foundation....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including protocols.io, are just a search away.